# Study Reveals Why Older Adults Are Using Cannabis Edibles | University of Utah Health

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/study-reveals-why-older-adults-are-using-cannabis-edibles-university-of-utah-health/
> **Published:** 2026-05-08T16:40:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:55:52-04:00
> **Clinical Summary:** University of Utah study reveals older adults use cannabis edibles for sleep and pain management. Clinical guidance for safe use in aging populations.

---

✦ New

 CED Clinical Relevance
 #72
 Notable Clinical Interest
 Emerging findings or policy developments worth monitoring closely.

ResearchAgingSleepPainSafety

 Why This Matters
 Clinicians need this information because older adults increasingly use [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) despite limited safety data in this population, and understanding their motivations for use (pain and sleep management) helps providers have informed conversations about efficacy, drug interactions, and age-related risks like falls and cognitive effects. Edibles present specific concerns for older adults including unpredictable absorption rates and delayed onset, which can lead to overdosing and adverse events that differ from smoking routes. Knowledge of why patients are turning to cannabis enables clinicians to discuss evidence-based alternatives and make individualized risk-benefit assessments rather than dismissing patient preferences.

 Clinical Summary

A University of Utah study examining [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns in older adults identifies sleep disturbance and [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) as primary motivations for initiating edible cannabis products in this population. The research reveals that older adults are increasingly turning to cannabis as an alternative to conventional pharmaceuticals, likely driven by concerns about medication side effects, drug interactions, and limited efficacy of traditional treatments for chronic conditions. Understanding these drivers is clinically significant because older adults have altered cannabis pharmacokinetics due to age-related changes in metabolism and body composition, making them particularly vulnerable to overdose and adverse effects from edibles, which have delayed and unpredictable onset compared to inhaled products. This population also commonly takes multiple medications that may interact with cannabinoids, and many lack comprehensive medical supervision of their [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), creating potential safety gaps in their care. Clinicians should proactively discuss cannabis use with older patients experiencing insomnia or [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), assess the adequacy of current analgesic and sleep regimens, and educate patients about the risks of edibles including delayed onset, prolonged effects, and cumulative dosing errors in this age group.

 Dr. Caplan’s Take
 “What we’re seeing in older adults is a rational response to real therapeutic limitations: they’ve often exhausted conventional options or can’t tolerate their side effects, and edibles offer predictable dosing without inhaling smoke into compromised lungs. The challenge for us as clinicians is that we have almost no geriatric safety data on cannabis, so we’re essentially asking patients to pioneer a treatment we don’t fully understand in a population most vulnerable to drug interactions and falls.”

 Clinical Perspective

This study highlighting cannabis edible use among older adults underscores an important clinical reality: our aging patients may be turning to cannabis products as perceived alternatives to conventional pharmaceuticals for common complaints like insomnia and [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), often without discussing these choices with their healthcare providers. While the appeal is understandable given concerns about opioid dependence and polypharmacy in older populations, clinicians should recognize that edibles present particular risks for this demographic, including delayed onset and prolonged effects that can increase fall risk, [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), and dangerous drug interactions with age-related medications. The gap between patient preference and evidence-based guidance suggests we need better communication about realistic efficacy, dosing challenges, and safety monitoring for cannabis in older adults, rather than assuming patients will spontaneously disclose use or understand product variability. Incorporating routine, non-judgmental cannabis screening into geriatric assessments and discussing safer alternatives like topical preparations

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Study%20Reveals%20Why%20Older%20Adults%20Are%20Using%20Cannabis%20Edibles%20%7C%20University%20of%20Utah%20Health%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D50842)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D50842)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Study%20Reveals%20Why%20Older%20Adults%20Are%20Using%20Cannabis%20Edibles%20%7C%20University%20of%20Utah%20Health%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D50842)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

 Related Articles

- [Study reveals why older adults are using cannabis edibles | EurekAlert!](https://cedclinic.com/study-reveals-why-older-adults-are-using-cannabis-edibles-eurekalert/)

- [Edible cannabis and pain, sleep, and mental health management in older adults](https://cedclinic.com/edible-cannabis-and-pain-sleep-and-mental-health-management-in-older-adults/)

- Cannabis and driving? Studies reveal big risks – Medical Xpress

📰 Source: [https://healthcare.utah.edu/newsroom/news/2026/05/study-reveals-why-older-adults-are-using-cannabis-edibles](https://healthcare.utah.edu/newsroom/news/2026/05/study-reveals-why-older-adults-are-using-cannabis-edibles)

Further Reading
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
